Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Healthcare Biotechnology Medical Instruments & Supplies
Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > KidneyCo
View:
Post by Biotec81 on Jan 10, 2023 3:54pm

KidneyCo

Is anyone following Baxters proposed spinoff of the renal care and acute therapies businesses?  I assume this is where pmx will land following fda approval.
Comment by pm1861 on Jan 10, 2023 9:48pm
Don't forget EAA.  Baxter again mentioned EAA and PMX in their January 6, 2023 investor call as near term launches.  Hopefully, the powers that be will give us some insight (soon) into how near we are... PM https://s22.q4cdn.com/911189824/files/doc_presentations/2023/Baxter-Investor-Announcement-010623.pdf
Comment by mercedesman on Jan 10, 2023 9:54pm
Yes and almost for sure ! Baxter's stock has been savaged in 2022 ...might have to pick some up as a value play.  They are trying to shake things up with a spinout ... just like DaVita and Medtronics are doing.  Kidneys are all the rage these days. Wait til they start counting the numbers post supply chain issues, post pandemic, and as more long-Covid takes hold.  ...more  
Spectral Medical Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities